Nick Foreman, MD
Pediatric Hematology / Oncology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
I have an interest in the development of clinical protocols for children with difficult to treat brain tumors. My lab interests concentrate on the development of novel therapies with glial tumors.
Specialties
- Pediatric Hematology / Oncology ( 1995 , 2006 )
- Pediatrics ( 1996 , 2004 )
Conditions & Treatments
-
Child and Teen Health
Pediatric Diseases and Conditions
-
Cancers
Brain Cancer, Chemotherapy, Pediatric Cancer
-
Brain and Nervous System
Brain Tumors
Education & Training
Medical Schools
MB ChB, Sheffield University (1981)
MD, Sheffield University (1981)
Internships
University of Sheffield (1982)
Residency Program
University of Sheffield (1985)
Fellowships
St. Jude Children's Research Hospital (1992)
Professional Memberships
American Society of Clinical Oncology, Member
Childhood Oncology Group, Member
Children’s Oncology Group - Ependymoma Sub-Committee, Co-Chair
Children’s Oncology Group Brain Tumor Committee, Member
Neuro Sciences Institute, Member
Royal College of Physicians (London), Member
Societe Internationale d’Oncologie International, Member
Research & Grants
Grants
Investigation of a Novel Cancer Stem Cell Population in Ependymoma (2019)
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma (2021)
Role of FACT in ZFTA-RelA fusion driven ependymoma (2023)
information for referring providers
Referral Contact Phone
(720) 777-6740
Clinical Interests for Referring Providers
I have an interest in the development of clinical protocols for children with difficult to treat brain tumors. My lab interests concentrate on the development of novel glial tumor therapies, specifically those directed at ependymoma and glioblastoma.
Research Interest for Referring Providers
I am interested in the following topics related to ependymoma: immunobiology and outcome; gene expression; therapy development; second look surgery; prognostic factors; and, the development of national and international protocols. Additionally, I study the following topics related to glioblastoma: Molecular biology of congenital and pediatric glioblastoma; Role of Sprouty-4 expression and WNT pathway in outcome; Gene expression analysis and correlation with novel therapeutics; Therapy development, local and multi-center protocol development; Development of high dose therapy, local and national protocol development. I, also, am very interested in developing high dose therapy local and national protocols for infant brain tumors, as well as the classification, genetic causation, and gene expression of infant brain tumors.
